Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Thank you for your comments. Looks like you have been following GrowLife longer than most on this board.
1M at .0314, bought at 0800 09Aug, the first price increase after Dr Gupta's essay. Long
Outstanding article on the value and brand power of GrowLife and Cannabis.org
1M shares long, right?
Thank you for your comments. It's highly organized and has great medical information, legal content, and real life testimonials.
As a MD/MBA, I respectfully disagree
Agreed
Um No
Very nice website. Great content, crisp. I'm amazed how much information there is!
One major difference is that PHOT reports independently audited SEC statements quarterly. Transparency is key for investment. No other company in this space does this.
Very nice analysis
Some of us are long players here- measured in years- not days, weeks, or months.
This is entertaining
Simple- price to sales ratio, which is typically used with small companies that do not have earnings.
$.22 implies the current price x 4, which implies a market capitalization of 120M. Estimated sales next year are $12-15M, implying a price to sales ratio of 10. That is a reasonable number.
May you share a depiction of the Fibonacci C as it relates to PHOT please?
Understood how you feel about the dilution. That is the critical issue with this company.
We are all equal here on the boards, I do pick up a lot of information. I have only one other experience with penny stocks, and that is with CNQR (.93 Nov 2011, now $111). I never traded, just held on to it. So I think it can be done- finding value in the penny sticks is difficult. PHOT might be a good play.
Yes, thank you. I have a MD and a MBA from a top business school. Appreciate your comments.
It is a question of tightening or having a loosening of credit conditions. The Fed continues to maintain easy credit conditions. That is good for us.
Great point. The dilution is the story here. Fortunately, the latest SEC filing of a new convertible gives us a respite of the $750k until next October. That is more than 150M shares that won't convert, which is very shareholder friendly.
Respectfully disagree. Under tightening conditions, riskier investments suffer. If the Fed is maintaining its easier credit conditions, that is favorable to the markets.
Growlife is an investment in infrastructure to support the medical cannabis industry. It obviates the need to enter the federal/state legal and medical controversies. The senior management are smart, well known attorneys who are leaders in advocating change for the relief of suffering, and are unusually transparent given their audited and regular SEC reporting.
This is a unique opportunity to invest with folks that have a strong ethical foundation for what they are trying to build- which is a better place for all of us.
I invite your attention to recent changes to the AMA's position on medical cannabis-
http://www.ama-assn.org/resources/doc/csaph/csaph-report3-i09.pdf
Very nice to see fellow healthcare professionals investing or trading in this singular opportunity.
Go PHOT
I am a physician with a masters in public health. There is no conclusive evidence that smoking cannabis causes lung cancer.
http://www.cancer.gov/cancertopics/pdq/cam/cannabis/healthprofessional/page5
Respectfully-I've done that. It took twelve years (CNQR .93 Nov 2001) but the trick was to stay Long.
Given the huge boost that the Department of Justice has given the industry, investors looking for a pure-play on the marijuana industry with strong fundamentals may want to take a closer look at GrowLife Inc. (OTCBB: PHOT). During the second quarter of 2013, the company reported revenue that jumped 460% to $872,000 due to its strategic acquisitions and product expansion. GrowLife's second quarter sales exceeded even MJNA's second quarter sales, and GrowLife appear to upward trending at much lower market cap of $25 million vs MJNA at almost $150 million market cap. We are particularly attentive to GrowLife because the "green light" provided by the Department of Justice is likely to encourage a lot more infrastructure building in the 20 states that already allow medical or recreational marijuana.
One would hope that finding multiple sources/channels of capital is a top priority for the senior executives. It is helpful there is a new CFO. Also helpful is their active search for a financial Advisory board, announced recently. But most importantly, and perhaps a fundamental realignment is the perception that banks can now participate in this industry, as evident by the DOJ policy memo on 29Aug and the Leahy Senate hearings last week.
That's possible. Next couple of years will be critical.
Great question.
This might be part of the answer- from Cannabis.org:
http://mmjbusinessdaily.com/2013/09/13/new-jersey-agrees-to-loan-a-dispensary-357200/
Dispensaries need equipment/expertise that GrowLife readily provides, nationally.
Please read the latest SEC statement concerning a new convertible note, which has decreased the dilutive effect for us in the next fiscal year. This was very shareholder friendly.
Absolutely. However:
What is groundbreaking about the new Growlife Hydroponics website is its organization. Gone are the seemingly random pictures of lights and equipment. Instead, there is order. It's consumer friendly. It proudly lists the 6 national stores prominently at the top. This is really great!
Growlife Hydroponics has a really crisp website and excellent video. This is new in the last month. http://www.growlifehydroponics.com/
Greed may not be consistent with strategic investors, who may see great value in providing sustained support to senior executives. By doing so our company's leaders can more readily execute their vision to build out an infrastucture in a wonderful new market.
Unlikely to be bought out. This senior management team believes in this company. It's their baby and they plan to grow for the long term.
Try Fidelity. $7 brokerage fee for 1M shares last month on Aug09. Took a few phone calls but the trade went through in 3 blocks.
I watched the interview 3 times. As a physician- I'm bemused- Sterling shows integrity. He is a visionary. And yet he is an attorney and sees all the angles of government regulation. He is an ideal person to lead this infrastructure change in the Marijuana industry.
The question remains on whether they will succeed in obtaining capital to fund their expansion. The recently announced advisory board working groups (legal, medical, financial, etc) is a great idea.